Published in Amyotroph Lateral Scler Frontotemporal Degener on May 01, 2013
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation (2015) 0.75
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2007) 3.93
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A (2007) 3.32
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc (2009) 3.30
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord (2007) 2.85
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2009) 2.76
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci (2008) 2.39
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet (2009) 2.22
Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J Clin Invest (2004) 2.21
Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest (2007) 2.18
The motor neuron response to SMN1 deficiency in spinal muscular atrophy. Muscle Nerve (2014) 2.02
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.93
Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med (2006) 1.85
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis (2011) 1.80
Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A (2004) 1.64
The outdoor air pollution and brain health workshop. Neurotoxicology (2012) 1.60
Inter- and intra-combinatorial regulation by transcription factors and microRNAs. BMC Genomics (2007) 1.45
Toward more efficient clinical trials for amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.45
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology. Thromb Haemost (2002) 1.44
Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve (2010) 1.43
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42
Disease recurrence after liver transplantation in Western Australia. J Gastroenterol Hepatol (2002) 1.41
Wolff-Parkinson-White syndrome in Patients With MELAS. Arch Neurol (2007) 1.29
Human B cell subsets. Adv Immunol (2008) 1.25
Missed opportunities for duchenne muscular dystrophy. J Pediatr (2009) 1.21
Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg Infect Dis (2003) 1.17
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One (2009) 1.12
Growth kinetics and competition between Methanosarcina and Methanosaeta in mesophilic anaerobic digestion. Water Environ Res (2006) 1.09
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol (2011) 1.08
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLoS One (2012) 1.08
Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci (2004) 1.07
Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol (2009) 1.07
Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females. Arch Neurol (2010) 1.06
Spinal muscular atrophy. Neurotherapeutics (2008) 1.06
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol (2005) 1.03
Carrier testing for spinal muscular atrophy. Genet Med (2010) 1.02
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging (2012) 1.02
Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol (2005) 1.01
Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscul Disord (2009) 1.01
Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. Commun Dis Intell Q Rep (2003) 0.99
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environ Health Perspect (2013) 0.98
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS One (2012) 0.95
Population structure of Cladophora-borne Escherichia coli in nearshore water of Lake Michigan. Water Res (2007) 0.95
Scoliosis surgery in children with neuromuscular disease: findings from the US National Inpatient Sample, 1997 to 2003. Arch Neurol (2010) 0.94
Efficiency perspectives on adaptive designs in stroke clinical trials. Stroke (2011) 0.94
A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood (2006) 0.94
Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers. Neurology (2014) 0.94
Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.93
Transient association of Ku with nuclear substrates characterized using fluorescence photobleaching. J Immunol (2002) 0.91
Effector CD4+ T cell expression signatures and immune-mediated disease associated genes. PLoS One (2012) 0.91
DNA cleavage of a cryptic recombination signal sequence by RAG1 and RAG2. Implications for partial V(H) gene replacement. J Biol Chem (2006) 0.90
Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries. Br J Clin Pharmacol (2002) 0.89
Human fetal, cord blood, and adult lymphocyte progenitors have similar potential for generating B cells with a diverse immunoglobulin repertoire. Blood (2004) 0.89
Implant Complications After Magnetically Controlled Growing Rods for Early Onset Scoliosis: A Multicenter Retrospective Review. J Pediatr Orthop (2017) 0.89
Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol (2002) 0.88
Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A (2009) 0.88
Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care (2004) 0.88
Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis (2006) 0.88
Clinical outcome measures in spinal muscular atrophy. J Child Neurol (2009) 0.88
Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord (2010) 0.87
A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol (2004) 0.87
Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord (2010) 0.87
Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. J Child Neurol (2010) 0.86
Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.85
Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. J Child Neurol (2011) 0.85
Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab (2011) 0.85
Optimizing catheter navigation for AF ablation: do not just follow the map! J Cardiovasc Electrophysiol (2007) 0.84
Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression. Blood (2008) 0.83
Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol (2010) 0.83
Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection. Respir Med (2011) 0.83
Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Neuroimaging Clin N Am (2003) 0.83
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PLoS One (2007) 0.83
Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: a clinical audit. Respirology (2011) 0.83
The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells. PLoS One (2013) 0.83
The green alga, Cladophora, promotes Escherichia coli growth and contamination of recreational waters in Lake Michigan. J Environ Qual (2009) 0.82
Large-scale risk prediction applied to Genetic Analysis Workshop 17 mini-exome sequence data. BMC Proc (2011) 0.82
Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscul Disord (2010) 0.82
SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One (2013) 0.82
Independent mobility after early introduction of a power wheelchair in spinal muscular atrophy. J Child Neurol (2012) 0.81
Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2. J Child Neurol (2012) 0.81
Web-based data management for a phase II clinical trial in ALS. Amyotroph Lateral Scler (2009) 0.81
Pityriasis lichenoides et varioliformis acuta: a rare association with the measles, mumps and rubella vaccine. Australas J Dermatol (2011) 0.81
Neuroscience networking: linking discovery to drugs. Neuropsychopharmacology (2012) 0.81
IgH V-region sequence does not predict the survival fate of human germinal center B cells. J Immunol (2005) 0.81
A novel tRNA(Val) mitochondrial DNA mutation causing MELAS. J Neurol Sci (2008) 0.81
Multi-scale temporal and spatial variation in genotypic composition of Cladophora-borne Escherichia coli populations in Lake Michigan. Water Res (2010) 0.80
Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides. J Exp Med (2002) 0.79
Genetic aspects of behavioral neurotoxicology. Neurotoxicology (2009) 0.79
Learning to walk: challenges for spinal muscular atrophy clinical trials. Neurology (2007) 0.79
Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit. Aust N Z J Obstet Gynaecol (2007) 0.78
Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy. J Child Neurol (2010) 0.78
Commonalities and challenges in the development of clinical trial measures in neurology. Neurotherapeutics (2015) 0.78
CD45RO enriches for activated, highly mutated human germinal center B cells. Blood (2007) 0.78
ALS Research Group (ALSRG): second meeting, a summary report. Amyotroph Lateral Scler (2006) 0.77
Randomized control trials in ALS: lessons learned. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.77
Motor Unit Estimate Number in the Anterior Tibial Muscle: Normative Data versus Findings in Critically Ill Patients in Intensive Care Units. J Clin Neuromuscul Dis (2002) 0.77